Fibroblast growth factor 21 as a candidate of a novel serum biomarker for mitochondrial diabetes

Yuji Komorita1,2,3, Akiyo Shiroozu1, Hidetoshi Nakamura1

  • 1Kokura Daiichi Hospital, Kitakyushu, Japan.